Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

AIMS: Most cardiac surgery patients, with or without diabetes, develop perioperative hyperglycaemia, for which intravenous insulin is the only therapeutic option. This is labour‐intensive and carries a risk of hypoglycaemia. We hypothesized that preoperative administration of the glucagon‐like pepti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Hulst, Abraham H., Visscher, Maarten J., Godfried, Marc B., Thiel, Bram, Gerritse, Bastiaan M., Scohy, Thierry V., Bouwman, R. Arthur, Willemsen, Mark G. A., Hollmann, Markus W., Preckel, Benedikt, DeVries, J. Hans, Hermanides, Jeroen
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079116/
https://ncbi.nlm.nih.gov/pubmed/31749275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13927
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars